Shen Hong, M.D.

Position:Vice Chair of Medical Oncology

Department:Medical Oncology

Medical School:Zhejiang University School of Medicine, China

Academic Rank:Chief Physician


Appointment

Clinical / Research Interests

Individualized therapy for patients of lung cancer, gastrointestinal cancer and breast cancer using chemotherapy, targeted therapy and biotherapy.

Professional Highlights

Zhejiang Medicine and Health Innovation Award, Second Prize

Professional Appointments

Member, Lung Cancer Committee, Chinese Pharmaceutical Education Committee, 2016- Present

Member, Chemotherapy Committee, Zhejiang Anti-Cancer Association, 2012- Present

Member, Anti-cancer Drugs Committee, Zhejiang Anti-Cancer Association, 2012- Present

Vice President, Tumor Markers Youth Committee, Zhejiang Anti-Cancer Association


Education Experience

Research Summary

Publications

Shen H, Cao Y, Li X et al. Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients. Medicine (Baltimore), 2016, 95(21):e3800.

Hong Shen, Jiao Yang, Qing Huang et al. Different treatment strategies and molecular features between right-sided and left-sided colon cancers. World J Gastroenterol, 2015, 21(21): 6470-6478

Yuan Y, Tan CW, Shen H et al. Identification of the Biomarkers for the Prediction of Efficacy in First-Line Chemotherapy of Metastatic Colorectal Cancer Patients using SELDI-TOF-MS and Artificial Neural Networks. Hepatogastroenterology. 2012,12;59(120).

Dong Xu, Wei Tian, Hong Shen. Curcumin Prevents Induced Drug Resistance: A Novel Function? Chin J Cancer Res, 2011, 23(3):218-223. 

Shen H, Yuan Y, Hu HG et al. Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients. World J Gastroenterol, 2011, 17(6):809-16. 

Shen H, Zhong X, Ge XQ, Huang JJ, Yuan Y. Surgical resection of lung adenocarcinoma without EGFR mutation after neoadjuvant gefitinib treatment. Clin Respir J, 2010,4(3):192-3. 

Yu Z, Shen H, Pan WS. Chemotherapy of early gastric cancer. J Practical Oncology, 2010, 25(5):503-506. 

Tang SY, Peng XD, Shen H et al. Evaluation of efficacy and toxicity of gemcitabine in combination with vinorelbine in metastatic breast cancer patients previously treated with anthracyclines and taxanes. J Practical Oncology, 2010, 25:308-310. 

Yuan Y, Hu HG, Ye XX, Shen H et,al. Relationship between mutated K-ras and clinicopathologic characteristics of colorectal cancer. Chinese journal of surgery, 2010, 48(16):1247-1251. 

Shen H, Pan WS, Yuan Y. Clinicopathologic study on gastric mini-cancer. Chin J General Surgery, 2009, 24(4):269-272. 

Shen H, Yuan Y, Song YM et al. Comparison of clinical and genetic phenotypes between Chinese and Korean HNPCC families. Chin J Med Genet, 2008, 25(3):326-330. 

Shen H, Fu YB,Wang HY et al. Oncocytic carcinoid tumor of the lung: clinical and pathological characteristics. Zhonghua Jie He He Hu Xi Za Zhi. 2008, 31(8):594-7.


Current Program

Find People

Search by Family Name

Find A Department

Search by Departments